Guardant Health
300 hedge funds and large institutions have $3.95B invested in Guardant Health in 2023 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 104 increasing their positions, 78 reducing their positions, and 53 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
82% more capital invested
Capital invested by funds: $2.17B → $3.95B (+$1.78B)
78% more call options, than puts
Call options by funds: $23.9M | Put options by funds: $13.4M
43% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 53
33% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 78
8% more funds holding
Funds holding: 278 → 300 (+22)
6.93% more ownership
Funds ownership: 90.02% → 96.95% (+6.9%)
Top Buyers
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$124M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$44M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$36.3M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$27.1M |
| 5 |
ClearBridge Investments
New York
|
-$21.6M |
GH Hedge Fund Activity: Q2 2023 in Review
300 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q2 2023, worth a combined $3.95B — up 82% from $2.17B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new GH positions and 53 closed out — a net gain of 23 holders — while 104 added to existing stakes and 78 trimmed.
The largest buyer was BlackRock, adding an estimated $109M. The largest seller was Capital International Investors, cutting an estimated $124M.
- 300 institutional investors held Guardant Health (GH) as of Q2 2023, up from 278 in Q1 2023.
- Funds reported $3.95B of Guardant Health stock for Q2 2023, up 82% quarter-over-quarter.
- 76 funds opened new Guardant Health positions in Q2 2023 and 53 closed out, a net change of +23 holders.
- The largest Guardant Health buyer in Q2 2023 was BlackRock, an estimated $109M added.
- The largest Guardant Health seller in Q2 2023 was Capital International Investors, an estimated $124M sold.
Based on aggregated 13F filings for Q2 2023.